Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950285 · ClinicalTrials.gov registry record · NA
Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 2,336
- Enrollment target
NCT02950285: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02950285 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 2,336 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02950285, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,336 participants
- Enrollment target
Study Summary
The overall goal is to improve outcomes among patients with atrial fibrillation (AF) by preventing stroke. The investigators propose to implement an automated algorithm using electronic medical record (EMR) data to alert physicians in a large primary care practice network at the Massachusetts General Hospital (MGH) of their patients with AF and elevated stroke risk that are not taking an anticoagulant for stroke prevention. The investigators hypothesize that interventions to notify physicians of such individuals may prompt reassessment for the need for anticoagulation, and thereby increase guideline-indicated anticoagulation rates. Additionally, in a survey component, physicians will characterize reasons for not pursuing anticoagulation in AF patients at elevated risk for stroke.
Interventions
- OTHER Baseline alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,336 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2017-05-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02950285
The ClinicalTrials.gov registry entry for NCT02950285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,336 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Baseline alert is the first listed.
NCT02950285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02950285 about?
NCT02950285 is a clinical study titled "Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation". The overall goal is to improve outcomes among patients with atrial fibrillation (AF) by preventing stroke. The investigators propose to implement an automated algorithm using electronic medical record (EMR) data to alert physicians in a large primary care practice network at the Massachusetts Genera...
What is the current status of trial NCT02950285?
This trial is currently completed. It is a NA study. The enrollment target is 2,336 participants. The study started on 2017-02-07. Estimated completion is 2017-05-07.
What interventions are being tested in trial NCT02950285?
The interventions under investigation include: Baseline alert (OTHER).
Who is sponsoring clinical trial NCT02950285?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.